Activated c-Met[pY1003]: A potential marker of intrinsic resistance and therapy target to restore sensitivity to gefitinib
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: P. A. Zucali, M. Gallegos Ruiz, E. Giovannetti, A. Destro, K. Floor, G. L. Ceresoli, J. A. Rodriguez, M. Roncalli, A. Santoro, G. Giaccone
Institution: IRCCS Humanitas Research Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2296627041
